Porcine reproductive and respiratory syndrome virus (PRRSv) modified-live vaccine reduces virus transmission in experimental conditions

Vaccine

Volumn 33, Issue 21, 2015, Pages 2493-2499

  Rose, N ^a,b   Renson, P ^a,b   Andraud, M ^a,b   Paboeuf, F ^a,b   Le Potier, M F ^a,b   Bourry, O ^a,b  

^a ANSES Laboratoire de Ploufragan Plouzané Niort   (France)

^b UNIVERSITÉ EUROPÉENNE DE BRETAGNE   (France)

Author keywords

Porcine reproductive and respiratory syndrome virus; Reproduction number; Transmission; Vaccination

Indexed keywords

LIVE VACCINE; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ARTICLE; BAYES THEOREM; BLOOD SAMPLING; CONTROLLED STUDY; GENOTYPE; NONHUMAN; PIGLET; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VACCINATION; VIRUS GENOME; VIRUS LOAD; VIRUS STRAIN; VIRUS TRANSMISSION; ANIMAL; DISEASE TRANSMISSION; IMMUNOLOGY; ISOLATION AND PURIFICATION; PIG; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PREVENTION AND CONTROL; TRANSMISSION; VIREMIA;

ANIMALS; DISEASE TRANSMISSION, INFECTIOUS; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SWINE; VACCINES, ATTENUATED; VIRAL LOAD; VIRAL VACCINES; VIREMIA;

EID: 84928590879     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.03.040     Document Type: Article

References (18)

1. Neumann E.J., Kliebenstein J.B., Johnson C.D., Mabry J.W., Bush E.J., Seitzinger A.H., et al. Assessment of the economic impact of porcine reproductive and respiratory syndrome on swine production in the United States. J Am Vet Med Assoc 2005, 227:385-392.
2. Fablet C., Marois-Créhan C., Simon G., Grasland B., Jestin A., Kobisch M., et al. Infectious agents associated with respiratory diseases in 125 farrow-to-finish pig herds: a cross-sectional study. Vet Microbiol 2012, 157:152-163.
3. Le Potier M.F., Blanquefort P., Morvan E., Albina E. Results of a control programme for the porcine reproductive and respiratory syndrome in the French 'Pays de la Loire' region. Vet Microbiol 1997, 55:355-360.
4. Rose N., Larour G., Le Diguerher G., Eveno E., Jolly J.P., Blanchard P., et al. Risk factors for porcine post-weaning multisystemic wasting syndrome (PMWS) in 149 French farrow-to-finish herds. Prev Vet Med 2003, 61:209-225.
5. Anses Hiérarchisation de 103 maladies animales présentes dans les filières ruminants, équidés, porcs, volailles et lapins en France métropolitaine - Avis de l'Anses, rapport d'expertise collective 2012, Anses, Paris, France.
6. Martelli P., Gozio S., Ferrari L., Rosina S., De Angelis E., Quintavalla C., et al. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: clinical protection and cell-mediated immunity. Vaccine 2009, 27:3788-3799.
7. Nodelijk G., De Jong M.C.M., Van Nes A., Vernooy J.C.M., Van Leengoed L.A.M.G., Pol J.M.A., et al. Introduction, persistence and fade-out of porcine reproductive and respiratory syndrome virus in a Dutch breeding herd: A mathematical analysis. Epidemiol Infect 2000, 124:173-182.
8. Charpin C., Mahé S., Keranflec'h A., Belloc C., Cariolet R., Le Potier M., et al. Infectiousness of pigs infected by the porcine reproductive and respiratory syndrome virus (PRRSv) is time-dependent. Vet Res 2012, 43:art n69.
9. Mondaca-Fernandez E., Meyns T., Munoz-Zanzi C., Trincado C., Morrison R.B. Experimental quantification of the transmission of porcine reproductive and respiratory syndrome virus. Can J Vet Res 2007, 71:157-160.
10. Nodelijk G., De Jong M.C.M., Van Leengoed L.A.M.G., Wensvoort G., Pol J.M.A., Steverink P.J.G.M., et al. A quantitative assessment of the effectiveness of PRRSV vaccination in pigs under experimental conditions. Vaccine 2001, 19:3636-3644.
11. Velthuis A.G.J., De Jong M.C.M., De Bree J., Nodelijk G., Van Boven M. Quantification of transmission in one-to-one experiments. Epidemiol Infect 2002, 128:193-204.
12. Pileri E., Gibert E., Soldevila F., García-Saenz A., Pujols J., Diaz I., et al. Vaccination with a genotype 1 modified live vaccine against porcine reproductive and respiratory syndrome virus significantly reduces viremia, viral shedding and transmission of the virus in a quasi-natural experimental model. Vet Microbiol 2015, 175:7-16.
13. Velthuis A.G.J., Bouma A., Katsma W.E.A., Nodelijk G., De Jong M.C.M. Design and analysis of small-scale transmission experiments with animals. Epidemiol Infect 2007, 135:202-217.
14. Ihaka R., Gentleman R. R: a language for data analysis and graphics. J Comput Graphical Stat 1996, 5:299-314.
15. SAS Institute Inc. SAS/STAT user's guide 2011, SAS Institute, Cary, NC, USA.
16. De Jong M.C., Kimman T.G. Experimental quantification of vaccine-induced reduction in virus transmission. Vaccine 1994, 12:761-766.
17. Velthuis A.G., De Jong M.C., Kamp E.M., Stockhofe N., Verheijden J.H. Design and analysis of an Actinobacillus pleuropneumoniae transmission experiment. Prev Vet Med 2003, 60:53-68.
18. Wills R.W., Zimmerman J.J., Swenson S.L., Yoon K-J., Hill H.T., Bundy D.S., et al. Transmission of PRRSV by direct, close, or indirect contact. J Swine Health Prod 1997, 5:213-218.